ECP

Synergy ECP Announces Acquisition of Software Engineering Firm SoftTech Solutions

Retrieved on: 
Tuesday, March 26, 2024

COLUMBIA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Synergy ECP , a provider of software engineering, cybersecurity and systems engineering services for the U.S. Intelligence Community and Department of Defense, today announced its acquisition of SoftTech Solutions , a custom software development firm that specializes in serving the U.S. Intelligence Community.

Key Points: 
  • COLUMBIA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Synergy ECP , a provider of software engineering, cybersecurity and systems engineering services for the U.S. Intelligence Community and Department of Defense, today announced its acquisition of SoftTech Solutions , a custom software development firm that specializes in serving the U.S. Intelligence Community.
  • The addition of SoftTech Solutions will expand Synergy ECP’s technical breadth into mission focused cloud engineering and data analytics domains.
  • Together, Synergy ECP and SoftTech Solutions will deliver solutions in the highest priority capability areas of the Intelligence Community, including Signals Intelligence (SIGINT), cybersecurity, cloud engineering, and data transport and analysis.
  • “Synergy ECP represents the ideal partner for SoftTech Solutions as we continue to serve our national security customers,” said Jane Lee, founder and Chief Executive Officer of SoftTech Solutions.

EyeCare Partners Announces New Refractive Cataract Anterior Segment Fellowship and Launch of ECP Foundation

Retrieved on: 
Thursday, April 4, 2024

EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting.

Key Points: 
  • EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting.
  • The company is launching two new initiatives to elevate eye care – the Refractive Cataract Anterior Segment (RCAS) Fellowship and the ECP Foundation.
  • This one-year program provides residency graduates comprehensive training in the latest advancements in refractive cataract and anterior segment surgeries.
  • “We implement this mission through three programs: ECP GIVES, ECP EDUCATES and ECP CARES,” said Amy Jones, ECP Foundation President.

Bixia Expands Trading Operations With Hansen

Retrieved on: 
Thursday, March 21, 2024

Under this agreement, Bixia will expand its trading capabilities by leveraging Hansen Trade’s modularity to add the FCR (Frequency Containment Reserve) and mFRR (Manual Frequency Restoration Reserve) Ancillary Services trading and automatic customer communication components.

Key Points: 
  • Under this agreement, Bixia will expand its trading capabilities by leveraging Hansen Trade’s modularity to add the FCR (Frequency Containment Reserve) and mFRR (Manual Frequency Restoration Reserve) Ancillary Services trading and automatic customer communication components.
  • This expansion builds upon Bixia’s current deployment of Hansen Trade for intraday trading , initiated earlier last year.
  • The Hansen Trade FCR module enables Bixia to operate automatically in the FCR market, including automatic bid sending and trade-result handling.
  • Introducing Hansen’s FCR and mFRR trading modules will significantly upgrade our trading-related service and provide our customers with a modern trading service experience.

Next Wave Energy Partners Announces Commercial Operations of Innovative Ethylene-to-Alkylate Production Facility

Retrieved on: 
Wednesday, March 20, 2024

Next Wave Energy Partners, LP (“Next Wave”), a portfolio company of Energy Capital Partners (ECP), today announced that its alkylate production facility, known as Project Traveler and located adjacent to the Houston Ship Channel in Pasadena, Texas, has achieved commercial operations.

Key Points: 
  • Next Wave Energy Partners, LP (“Next Wave”), a portfolio company of Energy Capital Partners (ECP), today announced that its alkylate production facility, known as Project Traveler and located adjacent to the Houston Ship Channel in Pasadena, Texas, has achieved commercial operations.
  • “We are extremely pleased that this innovative facility is now producing what we believe to be the world’s highest quality alkylate product,” said Next Wave Executive Chairman Patrick Diamond.
  • “ECP is proud to have partnered with Next Wave, a company that has been at the forefront of the U.S. energy revolution.
  • “By converting natural gas liquids and their derivatives into higher-value, fuel-efficient products, Next Wave has created a win-win scenario for feedstock suppliers and alkylate customers.”

Enermont and Solar Power Accelerator seal a strategic deal on installation in 2024 of 15 MWp rooftop based sun energy to boost climate transition under contracted power purchase agreements

Retrieved on: 
Tuesday, March 19, 2024

Enermont, domiciled in Hässleholm, in south Sweden is a highly specialised EPC-contractor on PV-solar and battery installations.

Key Points: 
  • Enermont, domiciled in Hässleholm, in south Sweden is a highly specialised EPC-contractor on PV-solar and battery installations.
  • Founded in 2018, Enermont has an impressive growth trajectory and track record with a focus on quality, delivery performance, operations and capital efficiency.
  • We are running and leading an exceptionally aspirational climate transition campaign to roll out distributed roofbased solar power generation.
  • Hence, we are honoured to team up with such a highly credible and reputable ECP contractor like Enermont, says Pär-Olof Johannesson, CEO and Co-Founder, Solar Power Accelerator AB.

Masdar to Acquire 50% Stake in Terra-Gen from Energy Capital Partners

Retrieved on: 
Tuesday, March 19, 2024

ECP, a leading investor across energy transition, electrification and decarbonization infrastructure assets, will fully exit its position in Terra-Gen in connection with the transaction.

Key Points: 
  • ECP, a leading investor across energy transition, electrification and decarbonization infrastructure assets, will fully exit its position in Terra-Gen in connection with the transaction.
  • Igneo Infrastructure Partners ("Igneo"), a global infrastructure investment manager, will retain its existing 50 percent stake in the company.
  • This transaction unites one of the largest independent renewable energy producers in the U.S. with Masdar – one of the fastest growing clean energy companies in the world.
  • John DiMarco, Managing Director at Igneo, said, "Igneo is excited to partner with Masdar on Terra-Gen's next phase of growth.

ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results

Retrieved on: 
Wednesday, February 28, 2024

Total shipments in the fourth quarter of 2023 were $140 million, versus $197 million in the fourth quarter of 2022.

Key Points: 
  • Total shipments in the fourth quarter of 2023 were $140 million, versus $197 million in the fourth quarter of 2022.
  • ACM announced that its SAPS cleaning tool has been qualified for revenue from a large US manufacturer in the fourth quarter of 2023.
  • Unless otherwise noted, the following figures refer to the fourth quarter of 2023 and comparisons are with the fourth quarter of 2022.
  • ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

Esperanza and Andros Capital Partners Announce Acquisition of Ursa Princess from ExxonMobil and Formation of Deepwater Gulf of Mexico Joint Venture

Retrieved on: 
Wednesday, February 21, 2024

The Ursa acquisition includes current production of ~8,500 Boe/d (82% oil) net to ExxonMobil’s interest as well as associated infrastructure, including the Ursa Tension Leg Platform (“Ursa TLP”) host facility.

Key Points: 
  • The Ursa acquisition includes current production of ~8,500 Boe/d (82% oil) net to ExxonMobil’s interest as well as associated infrastructure, including the Ursa Tension Leg Platform (“Ursa TLP”) host facility.
  • Ursa is operated by Shell Offshore Inc. (“Shell”), a subsidiary of Shell plc, a leading operator in the Deepwater GOM.
  • Upon Closing, ECP (15.96%) joins other non-operated working interest partners BP Exploration & Production Inc (22.69%) and ConocoPhillips (15.96%).
  • The privately negotiated acquisition represents ECP’s third investment in the GOM through its partnership with Cockrell Interests (“Cockrell”) since 2021.

Zenni® Optical Announces 'Zenni Business' Customers

Retrieved on: 
Tuesday, March 5, 2024

NOVATO, Calif., March 4, 2024 /PRNewswire/ -- Zenni Optical, the world's leading online eyewear retailer, today announced eye care solutions partnerships with four customers of Zenni Business, its recently-launched B2B platform.

Key Points: 
  • Zenni's B2B platform has its roots in an unmatched expertise developed during its more than two decades transforming the consumer eyewear industry.
  • Zenni Business intends to challenge an eye care industry plagued by high costs, stifled innovation and consumer access limitations.
  • With its vertically integrated business model that includes ownership of optical laboratories, manufacturing and logistics, frame design, technology and customer service, Zenni can control costs and help its business partners benefit from existing infrastructure and marketplace knowledge.
  • "We identified a strategic opportunity to revolutionize this industry, and the response to Zenni Business has been extremely positive.

Mallinckrodt Presents Data on Real-World Outcomes with THERAKOS™ CELLEX™ Photopheresis System Treatment at the 2024 Tandem Meetings

Retrieved on: 
Wednesday, February 21, 2024

DUBLIN, Feb. 21, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced a poster presentation of findings from a systematic literature review and meta-analysis of the safety, efficacy, and real-world outcomes of extracorporeal photopheresis (ECP) treatment for patients with steroid-refractory chronic graft-versus-host disease (SR-cGvHD).1 An analysis of 47 studies reporting on the THERAKOS™ CELLEX™ Photopheresis System showed that treatment of SR-cGvHD with ECP was associated with improvements in patients' overall survival (OS), failure-free survival (FFS), and overall response rate (ORR).1 The results will be shared in a poster presentation at the 2024 Tandem Meetings, the combined Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) taking place February 21-24, 2024 in San Antonio, TX.

Key Points: 
  • Skin-specific response at Months 2-3 and at Months 4-6 were 34.86% (95% CI: 13.26-65.21) and 54.22% (95% CI: 35.67-71.67), respectively.
  • Outcomes may be influenced by therapies not evaluated in the study and the clinical/health economics outcomes may not be solely attributable to THERAKOS ECP.
  • THERAKOS™ Photopheresis is contraindicated in:
    THERAKOS™ Photopheresis treatments should always be performed in locations where standard medical emergency equipment is available.
  • Please refer to the THERAKOS™ CELLEX™ Photopheresis System Operator Manual for a complete list of warnings and precautions and adverse events.